Annexon YTD Return
The ANNX YTD return is 17.33% with dividends reinvested through 07/16/2026. Investors often use YTD return to compare year-to-date performance across securities because current calendar year return information is important for tax planning.
This page shows ANNX YTD return, annualized return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.
| ANNX YTD Return Table | ||||||||||||||||||||||||||||||
ANNX YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare ANNX YTD return (see YTD Return Formula;
YTD Return vs Yield) versus benchmarks: YTD Return on S&P YTD Return on Dow YTD Return on Nasdaq 100 YTD Return on Russell 2000 YTD Return on Gold YTD Return on 10 Year Treasury |
| ANNX Share Performance |
| ANNX YTD Return Chart | |||
Also see: ANNX Average Annual Return | |||
| About Annexon Inc |
| Annexon, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in advancing a late-stage clinical platform of therapies for people living with classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Using its platform, it is identifying and characterizing the role of the complement pathway in three therapeutic areas: autoimmune, neurodegeneration and ophthalmology. Its lead candidate, ANX005, is an investigational monoclonal antibody (mAb), formulated for intravenous administration in a pivotal Phase III clinical trial for the treatment of patients with Guillain-Barre Syndrome (GBS). The ANNX YTD return is shown above.
The YTD Return on the ANNX YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether ANNX YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ANNX YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| ANNX Current Stock Quote |
Quotes delayed 20 minutes  Free ANNX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Annexon (ANNX) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
ANRO YTD Return ANTH YTD Return ANTX YTD Return ANVS YTD Return AORT YTD Return APDN YTD Return APEN YTD Return APGE YTD Return APLS YTD Return APLT YTD Return More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Video: Don't Forget Dividends in YTD Return!